General Information of Drug (ID: DMWSDZ9)

Drug Name
N-bis-(3-phenyl-propyl)9-oxo-fluorene-2,7-diamide Drug Info
Synonyms 9H-Fluorene-2,7-dicarboxamide, 9-oxo-N,N'-bis(3-phenylpropyl)-; 443794-40-9; SCHEMBL4158879; CTK1C7933
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
10117946
CAS Number
CAS 443794-40-9
TTD Drug ID
DMWSDZ9

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
GPI 18214 DMAY48N Discovery agent N.A. Investigative [2]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Poly [ADP-ribose] glycohydrolase (PARG) TT39J16 PARG_HUMAN Inhibitor [1]

References

1 Post-treatment with a novel PARG inhibitor reduces infarct in cerebral ischemia in the rat. Brain Res. 2003 Jul 18;978(1-2):99-103.
2 Treatment with a novel poly(ADP-ribose) glycohydrolase inhibitor reduces development of septic shock-like syndrome induced by zymosan in mice. Crit Care Med. 2004 Jun;32(6):1365-74.